<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Rickettsialpox
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Rickettsialpox
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Rickettsialpox
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Micah T McClain, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Daniel J Sexton, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Keri K Hall, MD, MS
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Apr 14, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Rickettsialpox is an uncommon, mite-borne rickettsial disease caused by the agent
         <em>
          Rickettsia akari
         </em>
         .
         <em>
          R. akari
         </em>
         was first isolated in 1946 from a patient, mites, and a naturally infected house mouse in Queens, New York [
         <a href="#rid1">
          1
         </a>
         ]. The disease was named rickettsialpox because of its resemblance to chickenpox. The etiologic agent was named
         <em>
          R. akari
         </em>
         because the causative agent belonged to the genus
         <em>
          Rickettsia
         </em>
         and because
         <em>
          akari
         </em>
         is Greek for "mite."
         <em>
          R. akari
         </em>
         has long been considered a member of the spotted fever group of rickettsiae of which
         <em>
          R. rickettsii
         </em>
         is the prototype. However, some experts have proposed that
         <em>
          R. akari
         </em>
         should be considered a member of the transitional group of
         <em>
          Rickettsia
         </em>
         along with
         <em>
          R. australis
         </em>
         and
         <em>
          R. felis
         </em>
         [
         <a href="#rid2">
          2
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7902.html" rel="external">
          "Biology of Rickettsia rickettsii infection"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          R. akari
         </em>
         is transmitted to the common house mouse (
         <em>
          Mus musculus
         </em>
         ) by the bloodsucking mite
         <em>
          Liponyssoides sanguineus
         </em>
         (formerly
         <em>
          Allodermanyssus sanguineus
         </em>
         ). The mouse serves as the usual reservoir for the disease, although
         <em>
          R. akari
         </em>
         has also been detected in Korean voles [
         <a href="#rid3">
          3
         </a>
         ].
         <em>
          L. sanguineus
         </em>
         is a small (0.75 to 1.5 mm), colorless arthropod that swells to many times its normal size after a blood meal and becomes bright red in color.
         <em>
          L. sanguineus
         </em>
         rarely bites humans when mice are plentiful. However, when mouse populations are reduced (eg, by vermin eradication programs), this mite will bite humans and transmit the disease. Although natural infection is thought to occur exclusively by the bite of an infected mite, transmission has occurred in laboratory settings via inhalation of infectious aerosols [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Occurrence
         </span>
         <span class="headingEndMark">
          —
         </span>
         Rickettsialpox has been detected in urban areas in New York, Pittsburgh, Cleveland, Boston, as well as Arizona, Utah, South Africa and the Ukraine. Although over 800 cases of rickettsialpox have been reported since the initial description of the infection in 1946, it is widely assumed that this infection is underrecognized and underreported [
         <a href="#rid5">
          5,6
         </a>
         ]. Rickettsialpox has also been described in homeless patients and in persons who use intravenous drugs [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
         Rickettsialpox may have a wider geographic occurrence than previously realized. For example,
         <em>
          R. akari
         </em>
         was isolated from a 36 year old man from Croatia, an area in which rickettsialpox had not been previously recognized [
         <a href="#rid8">
          8
         </a>
         ]. Similarly, others have speculated that
         <em>
          R. akari
         </em>
         is widespread in Europe [
         <a href="#rid9">
          9,10
         </a>
         ]. In another report, sera reactive with
         <em>
          R. akari
         </em>
         antigens were detected among patients from Mexican states of Yucatan and Jalisco who were initially thought to have dengue fever [
         <a href="#rid11">
          11
         </a>
         ]. Another serosurvey done in southern California suggested that
         <em>
          R. akari
         </em>
         or an
         <em>
          akari
         </em>
         -like rickettsiae are present in wild rodents in Orange County, California [
         <a href="#rid12">
          12
         </a>
         ]. A single case of rickettsialpox was diagnosed in a man who worked at a suburban golf course in North Carolina [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Incubation period
         </span>
         <span class="headingEndMark">
          —
         </span>
         The incubation period for rickettsialpox has not been conclusively established but is thought to range from 10 to 14 days. One patient developed fever nine days after an apparent single exposure to a known focus of infection. In a second, laboratory-acquired case, a primary lesion at the site of inoculation appeared on the seventh day and fever appeared ten days after exposure [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Rickettsialpox is characterized clinically by a triad of findings which occur in the following order:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Initial skin lesion at the site of the bite of the infected mite
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Abrupt onset of fever and constitutional symptoms such as chills and myalgia
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A papulovesicular rash
        </p>
        <p>
        </p>
        <p>
         Most cases have each of the features of this triad. The diagnosis should be suspected when these findings occur in the appropriate epidemiologic setting.
        </p>
        <p>
         Most patients have a mild illness, and full recovery can be seen even without treatment. In one review, only 12 of 144 patients required hospitalization [
         <a href="#rid15">
          15
         </a>
         ]. Fatal rickettsialpox has never been described.
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Initial lesion
         </span>
         <span class="headingEndMark">
          —
         </span>
         The initial lesion typically begins as a tiny papule that enlarges to 1 to 1.5 cm as it progressively vesiculates and then subsequently forms a dark black crust or eschar. Eschars develop in the majority (more than 80 to 90 percent) of patients and, in rare cases, there is more than one initial lesion [
         <a href="#rid14">
          14,15
         </a>
         ]. They can appear in virtually any location including the face, extremities, or trunk.
        </p>
        <p>
         The skin surrounding the initial lesion usually becomes erythematous and regional lymphadenopathy is often present. However, the initial lesion and the surrounding skin are rarely tender or pruritic. As a result, patients are often unaware of the initial lesion, which typically heals in two to three weeks without treatment and leaves a small scar at the site of the eschar.
        </p>
        <p>
         Biopsy of the initial lesion characteristically reveals epidermal and dermal necrosis with perivascular and periadnexal inflammation. Other findings on pathologic examination of skin biopsies include granulomatous inflammation, perivascular T cell infiltrates, and histiocytosis [
         <a href="#rid16">
          16
         </a>
         ]. In one study of 13 cases of rickettsialpox [
         <a href="#rid5">
          5
         </a>
         ], a lymphocytic vasculitis was described; in addition, fluorescent-antibody testing using anti-
         <em>
          R. rickettsii
         </em>
         globulin (which cross reacts with
         <em>
          R. akari
         </em>
         antigens) demonstrated organisms consistent with
         <em>
          R. akari
         </em>
         in five patients.
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Constitutional symptoms
         </span>
         <span class="headingEndMark">
          —
         </span>
         Constitutional symptoms typically appear abruptly several days after the initial lesion. Virtually all patients have fever and malaise. Headache is characteristically present and may occasionally be severe enough to suggest infection of the central nervous system, especially if stiff neck is present. The cerebrospinal fluid is typically normal [
         <a href="#rid15">
          15
         </a>
         ]. Individual patients may complain of photophobia, conjunctival injection, sore throat, nausea, or vomiting.
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Papulovesicular rash
         </span>
         <span class="headingEndMark">
          —
         </span>
         A generalized skin rash that is the hallmark of rickettsialpox may occur on the same day or from one to nine days after the onset of constitutional symptoms. The rash of rickettsialpox typically begins as a maculopapular eruption that quickly becomes papulovesicular. These lesions then scab and fall off without scarring. Lesions may be numerous or few in number. They can occur on the face, palms, soles and mucous membranes. In some cases the rash remains maculopapular and never becomes papulovesicular [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Laboratory findings
         </span>
         <span class="headingEndMark">
          —
         </span>
         Leukopenia is common during the early febrile stage of illness [
         <a href="#rid14">
          14,15
         </a>
         ]. The differential count may reveal a relative lymphocytosis. Hepatitis that resolves coincident with treatment may also occur [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of rickettsialpox can be made through serologic testing or detection of the organism. However, given the limitations of current diagnostics, treatment decisions are often made clinically in a patient with a typical clinical syndrome who lives in an endemic area where
         <em>
          L. sanguineus
         </em>
         and mice are known or suspected to be present. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above and
         <a class="local">
          'Epidemiology'
         </a>
         above and
         <a class="local">
          'Treatment'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H2177066151">
         <span class="h2">
          Serologic testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         The gold standard for diagnosis of rickettsialpox remains a fourfold rise in convalescent titers of indirect fluorescent antibodies using spotted fever group (SFG) antigens. Such tests are readily available through most state health departments and the Centers for Disease Control and Prevention.
        </p>
        <p>
         However, serologic analysis is rarely helpful in making treatment decisions for the acutely ill patient given the relatively short course of disease, and the late onset of IgG antibodies coupled with the need for both acute and convalescent serology for confirmation. In addition, these serologic methods cannot reliably distinguish rickettsialpox from other SFG rickettsial infections (including
         <em>
          R. rickettsii, R. parkeri
         </em>
         ,
         <em>
         </em>
         and others) since
         <em>
          R. akari
         </em>
         cross-reacts with other spotted fever group rickettsiae. (See
         <a class="medical medical_review" href="/z/d/html/7908.html" rel="external">
          "Other spotted fever group rickettsial infections"
         </a>
         .)
        </p>
        <p>
         A modification of the enzyme-linked immunosorbent assay (ELISA) test utilizing epitope saturation by specific monoclonal antibodies has been developed to serologically confirm the specific species of infective rickettsiae, although this is not yet widely available [
         <a href="#rid18">
          18
         </a>
         ]. Other serology-based diagnostic options include direct immunofluorescence assays that identify rickettsial organisms in paraffin-embedded biopsy tissue from patients with rickettsialpox [
         <a href="#rid19">
          19
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3077080041">
         <span class="h2">
          Direct methods for diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         During active disease, the diagnosis of rickettsialpox can be confirmed by detection of the organism via immunostaining or polymerase chain reaction (PCR) in a biopsy of an eschar or papulovesicular lesions, or rarely through isolation of the agent from the blood. A real-time multiplex PCR technique has been developed that can specifically identify
         <em>
          R. akari
         </em>
         in formalin-fixed paraffin-embedded skin biopsy specimens and can distinguish it from
         <em>
          R. rickettsii
         </em>
         and
         <em>
          R. parkeri
         </em>
         [
         <a href="#rid20">
          20
         </a>
         ]. However, PCR testing and isolation of the organism are only available in a few large medical centers with specialized laboratory facilities and access to specialized reagents.
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The most common disease to mimic rickettsialpox is chickenpox. Rickettsialpox can be distinguished from chickenpox by the following characteristics:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rickettsialpox usually has a coexistent eschar
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The lesions of chickenpox characteristically appear in crops in contrast to rickettsialpox
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The mature lesion of chickenpox is a vesicle compared to a papulovesicle with a prominent papular component in rickettsialpox
        </p>
        <p>
        </p>
        <p>
         Rickettsialpox can also be confused with other rickettsial diseases, including Mediterranean spotted fever, Queensland tick typhus, African tick bite fever,
         <em>
          R. parkeri
         </em>
         infection, scrub typhus, infection with
         <em>
          R. philipii
         </em>
         (the presumed agent of Pacific Coast Fever) [
         <a href="#rid21">
          21
         </a>
         ], and Siberian tick typhus. All of these infections may be associated with eschars, but only Queensland tick typhus and African tick bite fever have rashes that are typically or occasionally vesicular. Furthermore, these illnesses occur in restricted geographic areas and a history of travel or residence in an endemic area can usually be elicited. (See
         <a class="medical medical_review" href="/z/d/html/7908.html" rel="external">
          "Other spotted fever group rickettsial infections"
         </a>
         .)
        </p>
        <p>
         Patients with an enteroviral infection may occasionally have an illness that mimics rickettsialpox, but they generally lack eschar and a true vesiculopapular eruption. Rarely, patients with disseminated gonococcal infection have vesiculopustular lesions that superficially resemble the lesions of rickettsialpox; however, these lesions do not form eschars. Rickettsialpox has also been confused with cutaneous anthrax [
         <a href="#rid6">
          6
         </a>
         ]. However, patients with cutaneous anthrax characteristically have local edema out of proportion to the size of the lesions and Gram stain of these lesions should reveal nonsporulating gram-positive rods. (See
         <a class="medical medical_review" href="/z/d/html/5533.html" rel="external">
          "Clinical manifestations and diagnosis of anthrax"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h1">
          TREATMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         We recommend treating all patients with suspected rickettsialpox. Although though the disease is usually self-limited, treatment may reduce the duration of symptoms. Given the limitations of current diagnostics, treatment decisions are often based upon typical clinical manifestations in a patient with epidemiologic risk factors. (See
         <a class="local">
          'Epidemiology'
         </a>
         above and
         <a class="local">
          'Clinical manifestations'
         </a>
         above and
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
         The treatment of choice for rickettsialpox in all patients is
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         200 mg orally as a loading dose and then 100 mg orally every 12 hours until the patient has been afebrile and clinically well for 48 to 72 hours. We administer doxycycline even to pregnant women and young children. Although tetracyclines other than doxycycline are generally contraindicated in these groups, doxycycline has not been associated with serious adverse events in pregnant women or children &lt;8 years old. A more detailed discussion of the use of doxycycline in children and pregnant women is found elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/7912.html" rel="external">
          "Treatment of Rocky Mountain spotted fever", section on 'Pregnant women'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7912.html" rel="external">
          "Treatment of Rocky Mountain spotted fever", section on 'Children'
         </a>
         .)
        </p>
        <p>
         The only alternative agent with clinical data to support its use is
         <a class="drug drug_general" data-topicid="9241" href="/z/d/drug information/9241.html" rel="external">
          chloramphenicol
         </a>
         . However, since rickettsialpox is typically a mild, self-limited infection, we recommend not treating with this drug given its risk of potential severe adverse reactions.
        </p>
        <p>
         In a report of 25 patients from a New York City hospital, oxytetracycline, chlortetracycline, or
         <a class="drug drug_general" data-topicid="9241" href="/z/d/drug information/9241.html" rel="external">
          chloramphenicol
         </a>
         (at doses of 250 mg orally every six hours) led to resolution of fever and other systemic signs of infection within 48 hours of the institution of therapy in all 25 patients [
         <a href="#rid22">
          22
         </a>
         ]. A similar response was demonstrated in a subsequent report of 13 patients; all of those who were treated with
         <a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">
          tetracycline
         </a>
         became afebrile within 24 hours [
         <a href="#rid5">
          5
         </a>
         ].
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          Doxycycline
         </a>
         was also associated with prompt recovery in an HIV-infected patient with rickettsialpox, despite immunohistochemical staining of biopsied lesions showing relatively large numbers of rickettsiae [
         <a href="#rid23">
          23
         </a>
         ]. A number of novel tetracycline-like agents (
         <a class="drug drug_general" data-topicid="9458" href="/z/d/drug information/9458.html" rel="external">
          tigecycline
         </a>
         ,
         <a class="drug drug_general" data-topicid="118878" href="/z/d/drug information/118878.html" rel="external">
          eravacycline
         </a>
         , and
         <a class="drug drug_general" data-topicid="119253" href="/z/d/drug information/119253.html" rel="external">
          omadacycline
         </a>
         ) have shown strong activity in vitro against
         <em>
          Rickettsial
         </em>
         spp and may offer additional effective alternatives, although clinical data on their use is limited [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1772221">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rickettsialpox is an uncommon, mite-borne rickettsial disease caused by the agent
         <em>
          Rickettsia akari
         </em>
         . The disease was named rickettsialpox because of its resemblance to chickenpox. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          R. akari
         </em>
         is transmitted to the common house mouse by a bloodsucking mite. The mouse serves as the reservoir for the disease. When mouse populations are reduced, this mite will bite humans and transmit the disease. Although natural infection is thought to occur exclusively by the bite of an infected mite, transmission has occurred in laboratory settings via inhalation of infectious aerosols. (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The incubation period for rickettsialpox has not been conclusively established, but is thought to range from 10 to 14 days. (See
         <a class="local">
          'Incubation period'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rickettsialpox is characterized clinically by a triad of findings including the initial skin lesion at the site of the bite followed by abrupt onset of fever, chills, myalgias and a generalized papulovesicular rash. The initial lesion typically begins as a tiny papule that vesiculates and subsequently forms an eschar. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The diagnosis of rickettsialpox is often a clinical one based upon characteristic symptoms and signs. A diagnosis of rickettsialpox can be established retrospectively by documenting a fourfold rise in convalescent titers of complement fixation or indirect fluorescent antibodies using spotted fever group antigens. The diagnosis can also be confirmed by detection of the organism via immunostaining or polymerase chain reaction testing. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The most common disease to mimic rickettsialpox is chickenpox. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The treatment of choice for rickettsialpox is
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         (200 mg orally as a loading dose and then 100 mg orally every 12 hours) until the patient has been afebrile and clinically well for 48 to 72 hours. (See
         <a class="local">
          'Treatment'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Public Health Weekly Reports for NOVEMBER 8, 1946. Public Health Rep 1946; 61:1605.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Csicsay F, Flores-Ramirez G, Zuñiga-Navarrete F, et al. Proteomic analysis of Rickettsia akari proposes a 44 kDa-OMP as a potential biomarker for Rickettsialpox diagnosis. BMC Microbiol 2020; 20:200.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           JACKSON EB, DANAUSKAS JX, COALE MC, SMADEL JE. Recovery of Rickettsia akari from the Korean vole Microtus fortis pelliceus. Am J Hyg 1957; 66:301.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           SLEISENGER MH, MURRAY ES, COHEN S. Rickettsialpox case due to laboratory infection. Public Health Rep 1951; 66:311.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kass EM, Szaniawski WK, Levy H, et al. Rickettsialpox in a New York City hospital, 1980 to 1989. N Engl J Med 1994; 331:1612.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koss T, Carter EL, Grossman ME, et al. Increased detection of rickettsialpox in a New York City hospital following the anthrax outbreak of 2001: use of immunohistochemistry for the rapid confirmation of cases in an era of bioterrorism. Arch Dermatol 2003; 139:1545.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brouqui P, Raoult D. Arthropod-borne diseases in homeless. Am J Trop Med Hyg 2006; 1078:223.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Radulovic S, Feng HM, Morovic M, et al. Isolation of Rickettsia akari from a patient in a region where Mediterranean spotted fever is endemic. Clin Infect Dis 1996; 22:216.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brouqui P, Parola P, Fournier PE, Raoult D. Spotted fever rickettsioses in southern and eastern Europe. FEMS Immunol Med Microbiol 2007; 49:2.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paddock CD, Koss T, Eremeeva ME, et al. Isolation of Rickettsia akari from eschars of patients with rickettsialpox. Am J Trop Med Hyg 2006; 75:732.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zavala-Velazquez JE, Yu XJ, Walker DH. Unrecognized spotted fever group rickettsiosis masquerading as dengue fever in Mexico. Am J Trop Med Hyg 1996; 55:157.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bennett SG, Comer JA, Smith HM, Webb JP. Serologic evidence of a Rickettsia akari-like infection among wild-caught rodents in Orange County and humans in Los Angeles County, California. J Vector Ecol 2007; 32:198.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krusell A, Comer JA, Sexton DJ. Rickettsialpox in North Carolina: a case report. Emerg Infect Dis 2002; 8:727.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           ROSE HM. The clinical manifestations and laboratory diagnosis of rickettsialpox. Ann Intern Med 1949; 31:871.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greenberg M, Pellitteri O. Rickettsialpox. Bull N Y Acad Med 1947; 23:338.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vyas NS, Shieh WJ, Phelps RG. Investigating the histopathological findings and immunolocalization of rickettsialpox infection in skin biopsies: A case series and review of the literature. J Cutan Pathol 2020; 47:451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Madison G, Kim-Schluger L, Braverman S, et al. Hepatitis in association with rickettsialpox. Vector Borne Zoonotic Dis 2008; 8:111.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Radulovic S, Speed R, Feng HM, et al. EIA with species-specific monoclonal antibodies: a novel seroepidemiologic tool for determination of the etiologic agent of spotted fever rickettsiosis. J Infect Dis 1993; 168:1292.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walker DH, Hudnall SD, Szaniawski WK, Feng HM. Monoclonal antibody-based immunohistochemical diagnosis of rickettsialpox: the macrophage is the principal target. Mod Pathol 1999; 12:529.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Denison AM, Amin BD, Nicholson WL, Paddock CD. Detection of Rickettsia rickettsii, Rickettsia parkeri, and Rickettsia akari in skin biopsy specimens using a multiplex real-time polymerase chain reaction assay. Clin Infect Dis 2014; 59:635.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Padgett KA, Bonilla D, Eremeeva ME, et al. The Eco-epidemiology of Pacific Coast Tick Fever in California. PLoS Negl Trop Dis 2016; 10:e0005020.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           ROSE HM. The treatment of rickettsialpox with antibiotics. Ann N Y Acad Sci 1952; 55:1019.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sanders S, Di Costanzo D, Leach J, et al. Rickettsialpox in a patient with HIV infection. J Am Acad Dermatol 2003; 48:286.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quade BR, Ramírez-Hernández A, Blanton LS. In Vitro Susceptibility of Rickettsia Species to Eravacycline, Omadacycline, and Tigecycline. Antimicrob Agents Chemother 2021; 65:e0066521.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 7909 Version 15.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19316103" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Public Health Weekly Reports for NOVEMBER 8, 1946.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32640994" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Proteomic analysis of Rickettsia akari proposes a 44 kDa-OMP as a potential biomarker for Rickettsialpox diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13478580" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Recovery of Rickettsia akari from the Korean vole Microtus fortis pelliceus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14816492" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Rickettsialpox case due to laboratory infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7969341" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Rickettsialpox in a New York City hospital, 1980 to 1989.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14676069" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Increased detection of rickettsialpox in a New York City hospital following the anthrax outbreak of 2001: use of immunohistochemistry for the rapid confirmation of cases in an era of bioterrorism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Arthropod-borne diseases in homeless
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8838175" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Isolation of Rickettsia akari from a patient in a region where Mediterranean spotted fever is endemic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17266709" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Spotted fever rickettsioses in southern and eastern Europe.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17038703" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Isolation of Rickettsia akari from eschars of patients with rickettsialpox.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8780453" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Unrecognized spotted fever group rickettsiosis masquerading as dengue fever in Mexico.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18260508" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Serologic evidence of a Rickettsia akari-like infection among wild-caught rodents in Orange County and humans in Los Angeles County, California.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12095443" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Rickettsialpox in North Carolina: a case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15393018" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : The clinical manifestations and laboratory diagnosis of rickettsialpox.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19312537" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Rickettsialpox.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31955452" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Investigating the histopathological findings and immunolocalization of rickettsialpox infection in skin biopsies: A case series and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18171106" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Hepatitis in association with rickettsialpox.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7693827" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : EIA with species-specific monoclonal antibodies: a novel seroepidemiologic tool for determination of the etiologic agent of spotted fever rickettsiosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10349992" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Monoclonal antibody-based immunohistochemical diagnosis of rickettsialpox: the macrophage is the principal target.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24829214" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Detection of Rickettsia rickettsii, Rickettsia parkeri, and Rickettsia akari in skin biopsy specimens using a multiplex real-time polymerase chain reaction assay.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27706171" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : The Eco-epidemiology of Pacific Coast Tick Fever in California.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13139180" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : The treatment of rickettsialpox with antibiotics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12582406" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Rickettsialpox in a patient with HIV infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34060898" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : In Vitro Susceptibility of Rickettsia Species to Eravacycline, Omadacycline, and Tigecycline.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
